275.19 USD
▲-1.90+1.79%
盘后 268.02 0.00%
2026-07-31
市值
$39.41B
市盈率
—
EPS
-1.64
股息率
—
52 周区间
131.81 – 288.04
成交量
1.92M
Beta
1.50
目标价
282.86
52W 低 131.8152W 高 288.04
价格走势
公司简介
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizo...